An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211776
Company: CIPLA

Products on ANDA 211776

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DIFLUPREDNATE	DIFLUPREDNATE	0.05%	EMULSION;OPHTHALMIC	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 211776

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/09/2021	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/211776Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 211776

DIFLUPREDNATE

EMULSION;OPHTHALMIC; 0.05%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DIFLUPREDNATE	DIFLUPREDNATE	0.05%	EMULSION;OPHTHALMIC	Prescription	No	AB	211526	AMNEAL
DIFLUPREDNATE	DIFLUPREDNATE	0.05%	EMULSION;OPHTHALMIC	Prescription	No	AB	211776	CIPLA
DIFLUPREDNATE	DIFLUPREDNATE	0.05%	EMULSION;OPHTHALMIC	Prescription	No	AB	214894	DR REDDYS
DUREZOL	DIFLUPREDNATE	0.05%	EMULSION;OPHTHALMIC	Prescription	Yes	AB	022212	SANDOZ

Top